Insider trades
Bios Advisors GP, Director of Cognition Therapeutics CGTX, has filed 9 purchases and 64 sales on the open market. The latest trade was on 06/17.
Bios Advisors GP
Director
- Company
- Cognition Therapeutics CGTX
- First filing
- 23/06/13
- Trades
- 172 trades
- Buys / sales
- 9 / 64
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/06/27 | 25/06/30 | 71,428 sh | $7.00 | $499,996 | +57.1% | |
LTRN | Open-market sale | 25/06/10–25/06/13 | 25/06/13 | 101,613 sh20 trades | $3.27avg. | $331,871.26 | −47.1% |
LTRN | Open-market sale | 25/05/27–25/05/29 | 25/05/29 | 56,237 sh15 trades | $2.99avg. | $168,418.85 | −31.0% |
ACTU | Open-market saleAmendment | 24/08/14 | 24/08/20 | 24,999 sh3 trades | $8.00avg. | $199,992 | −16.0% |
ACTU | Open-market buy | 24/08/14 | 24/08/14 | 500,000 sh2 trades | $8.00avg. | $4,000,000 | No record |
ACTU | Open-market sale | 24/08/14 | 24/08/14 | 24,999 sh3 trades | $9.00avg. | $224,991 | −16.0% |
LTRN | Open-market sale | 24/05/23–24/05/24 | 24/05/28 | 30,000 sh6 trades | $6.30avg. | $189,100 | −18.6% |
LTRN | Open-market sale | 24/02/27–24/02/29 | 24/02/29 | 144,000 sh9 trades | $4.70avg. | $676,294.06 | −51.1% |
LTRN | Open-market sale | 24/01/17 | 24/01/19 | 58,889 sh3 trades | $4.20avg. | $247,333.8 | −25.9% |
LTRN | Open-market sale | 23/11/29 | 23/12/01 | 145,348 sh2 trades | $3.44avg. | $499,997.12 | −28.1% |
AZTR | Open-market buy | 23/06/21 | 23/06/23 | 2,297,490 sh6 trades | No stated value | No stated value | No record |
AZTR | Open-market sale | 23/06/21 | 23/06/23 | 669,317 sh3 trades | No stated value | No stated value | −100.0% |
